Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase 2”

41,126 trials

Showing 20 of 41,126 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05608876
What this trial is testing

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
QBiotics Group Limited 15
Testing effectiveness (Phase 2)WithdrawnNCT05170789
What this trial is testing

Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Tulane University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT04036968
What this trial is testing

Enhancing Medication-based Analgesia in Humans- STUDY 2

Who this might be right for
PainCannabisOpioid Use
Johns Hopkins University 31
Testing effectiveness (Phase 2)UnknownNCT05005468
What this trial is testing

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.

Who this might be right for
NSCLC
Shanghai Chest Hospital 61
Testing effectiveness (Phase 2)Study completedNCT00006450
What this trial is testing

Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain Tumor
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Study completedNCT03863574
What this trial is testing

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Zydus Therapeutics Inc. 16
Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Testing effectiveness (Phase 2)Looking for participantsNCT06561360
What this trial is testing

Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

Who this might be right for
Hairy Cell Leukemia
Memorial Sloan Kettering Cancer Center 86
Not applicableStudy completedNCT05257460
What this trial is testing

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

Who this might be right for
Type 1 Diabetes
University of Cambridge 28
Testing effectiveness (Phase 2)Study completedNCT05868382
What this trial is testing

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 270
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07040280
What this trial is testing

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

Who this might be right for
Melanoma
Eastern Cooperative Oncology Group 120
Testing effectiveness (Phase 2)UnknownNCT00003327
What this trial is testing

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Theradex 60
Testing effectiveness (Phase 2)UnknownNCT04296786
What this trial is testing

Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

Who this might be right for
Cutaneous T-cell Lymphoma
Peking Union Medical College Hospital 52
Testing effectiveness (Phase 2)Study completedNCT01471470
What this trial is testing

Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Asan Medical Center 31
Testing effectiveness (Phase 2)WithdrawnNCT00005969
What this trial is testing

Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00511069
What this trial is testing

Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia

Who this might be right for
Leukemia
University of Bologna 3
Testing effectiveness (Phase 2)Study completedNCT01259869
What this trial is testing

PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

Who this might be right for
Glioblastoma
NCIC Clinical Trials Group 34
Early research (Phase 1)Study completedNCT02169583
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

Who this might be right for
Infections, Respiratory Tract
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)WithdrawnNCT03623776
What this trial is testing

Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.

Who this might be right for
Efficacy and Safety
Sun Yat-sen University
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation